Cargando…
Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection
The SARS-CoV-2 pandemic has focused attention on prevention, restriction and treatment methods that are acceptable worldwide. This means that they should be simple and inexpensive. This review examines the possible role of glycosaminoglycan (GAG) antithrombotics in the treatment of COVID-19. The pat...
Autor principal: | Magnani, Harry N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868468/ https://www.ncbi.nlm.nih.gov/pubmed/33539214 http://dx.doi.org/10.1177/1076029620977702 |
Ejemplares similares
-
Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence-
por: Godino, Cosmo, et al.
Publicado: (2021) -
The rationale for using low-molecular weight heparin in the therapy of symptomatic COVID-19 patients
por: Reichman-Warmusz, Edyta, et al.
Publicado: (2022) -
Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence
por: van Haren, Frank M. P., et al.
Publicado: (2020) -
Is there a rationale for heparin use among severe COVID-19 patients?
por: Savioli, Felicio
Publicado: (2020) -
SPR Biosensor Probing the Interactions between TIMP-3 and Heparin/GAGs
por: Zhang, Fuming, et al.
Publicado: (2015)